Forma Therapeutics
AcquiredUnited States · $125.5M raised
- Employees
- 51–200
- Total Funding
- $125.5M
- Last Round
- $100.0M Series DDec 2019
- Rounds
- 2
- Acquisition Date
- Sep 2022
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Clinical-stage company focused on rare hematologic diseases and cancers; acquired by Novo Nordisk in 2022
Summary
Forma Therapeutics is a Biotech company based in United States. It has raised $125.5M in total across 2 rounds, most recently a $100.0M Series D round in Dec 2019. Investors include RA Capital Management, Cormorant Asset Management and Wellington Management.
Funding & Exit History
Sep 2022
Sign up to see all 3 events
Funding: Series B through Series D. Amounts, valuations, and investors where available.
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/forma-therapeutics"><img src="https://indexed.vc/api/badge/company/forma-therapeutics" alt="Forma Therapeutics on Indexed.vc" width="260" height="76" /></a>
